1-6 of 6
Jaroslav Polak
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Importance of Transcription Factor Nrf2 for Cereblon Expression and Clinical Response to Combination of Lenalidomide and Erythropoietin in Lower-Risk Myelodysplastic Syndromes

Radka Bokorová, MSc, Jaroslav Polak, MSc, Anna Jonasova, MD, Radana Neuwirtova, MD PhD, Marie Lauermannova, MD, Jaroslav Cermak, MD PhD, Marketa Stastna, MD PhD, Cyril Salek, Dana Mikulenkova, MD, Zuzana Zemanova, PhD, Jana Brezinova, Kyra Michalova, PhD, Denisa Myslivcova, PhD, Ota Fuchs, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5507.
https://doi.org/10.1182/blood-2018-99-115803
Published: 2018
Journal Articles

Measurement of Increase in Cereblon mRNA Level after Addition of Erythropoietin to Lenalidomide May Predict a Clinical Response to Combination of Both the Drugs in Patients with Lower-Risk Myelodysplastic Syndromes

Radka Bokorová, Jaroslav Polak, MSc, Arnost Kostecka, Anna Jonasova, MD PhD, Radana Neuwirtova, MD PhD, Tomas Stopka, MD PhD Assoc Proff, Marie Lauermannova, Jaroslav Cermak, MD PhD, Dana Mikulenkova, Zuzana Zemanova, PhD, Jana Brezinova, PhD, Ota Fuchs, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5295.
https://doi.org/10.1182/blood.V130.Suppl_1.5295.5295
Published: 2017
Journal Articles

High Cereblon Expression In Lower Risk Myelodysplastic Syndromes With 5q Deletion Is Associated With The Efficacy Of Lenalidomide

Anna T Jonasova, MD, Jaroslav Polak, Martin Vostry, Arnost Kostecka, Radka Bokorova, Radana Neuwirtova, MD, PhD, Magda Siskova, MD, Miroslav Caniga, Dana Sponerova, Jaroslav Cermak, Dana Mikulenková, MD, Jana Brezinova, PhD, Kyra Michalova, PhD, Ota Fuchs, PhD
Journal: Blood
Blood (2013) 122 (21): 1529.
https://doi.org/10.1182/blood.V122.21.1529.1529
Published: 2013
Journal Articles

Significance of Minimal Residual Disease Monitored by Quantitative Assessment of WT1gene in Patients in First Remission of Acute Myeloid Leukemia Before Allogeneic Stem Cell Transplantation

Veronika Válková, Jaroslav Polak, Marketa Markova, Hana Hájková, Antonin Vitek, Mariana Hricinová, Dana Mikulenková, Jaroslav Cermak, MD, PhD, Petr Cetkovsky
Journal: Blood
Blood (2011) 118 (21): 4485.
https://doi.org/10.1182/blood.V118.21.4485.4485
Published: 2011
Journal Articles

Expression Analysis of WT1 Splicing Variants In CML and AML: −5/+KTS as a Novel Candidate for Early Marker of Relapse

Tereza Lopotova, Jaroslav Polak, Hana Klamova, Jiri Schwarz, Jana Moravcova
Journal: Blood
Blood (2010) 116 (21): 2749.
https://doi.org/10.1182/blood.V116.21.2749.2749
Published: 2010
Journal Articles

Expression of Four Major WT1 Splicing Variants in AML and CML: Development of Quantitative Real-Time PCRs and Preliminary Results in Patient Samples.

Tereza Lopotova, Jana Moravcova, Vaclava Polivkova, Jaroslav Polak, Jiri Schwarz, Hana Klamova, Katerina Machova Polakova
Journal: Blood
Blood (2009) 114 (22): 1631.
https://doi.org/10.1182/blood.V114.22.1631.1631
Published: 2009